August is SMA Awareness Month!

The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month, an effort that Cure SMA has been coordinating since 1996. Throughout August, the community works together to raise the general public’s awareness of SMA by hosting candlelight vigils, contacting their local legislature, holding fundraisers, coordinating MLB awareness games, and providing information to local […]

August is SMA Awareness Month! Read More »

Biogen Releases Update on Spinraza Access

On Monday, Biogen released an update detailing our community’s progress in gaining access to Spinraza. The latest update shows that significant progress has been made in making Spinraza broadly available to those impacted by SMA. The update includes: 233 sites have begun the process for administering Spinraza, 145 of those sites now actively dosing. More

Biogen Releases Update on Spinraza Access Read More »

Call to Action: Senate Expected to Vote on Healthcare Bill Today

Today, members of the Senate are scheduled to begin voting on the Better Care Reconciliation Act (“Better Care Act”) of 2017. This is the Senate’s version of legislation modifying key parts of the Patient Protection and Affordable Care Act (ACA) in response to the American Health Care Act (AHCA) passed by the House of Representatives

Call to Action: Senate Expected to Vote on Healthcare Bill Today Read More »

Missouri is the First State to Institute Newborn Screening for Spinal Muscular Atrophy

Governor Eric Greitens today signed into law Missouri Senate Bill 50, instituting newborn screening for spinal muscular atrophy (SMA). The bill makes Missouri the first state in the country to screen all newborns for SMA. The legislation was sponsored by Representative Becky Ruth, a legislator with a longstanding commitment to expanding newborn screening efforts. Newborn

Missouri is the First State to Institute Newborn Screening for Spinal Muscular Atrophy Read More »

Cure SMA Launches Newborn Screening Grassroots Advocacy Campaign for Spinal Muscular Atrophy Newborn Screening

Today, as part of the Annual SMA Conference, we announced the launch of a new grassroots advocacy campaign to implement newborn screening for spinal muscular atrophy. Today’s kick-off event is a symposium on newborn screening advocacy, held as part of the Annual SMA Conference in Orlando, FL. One state, Missouri, has legislation pending instituting statewide

Cure SMA Launches Newborn Screening Grassroots Advocacy Campaign for Spinal Muscular Atrophy Newborn Screening Read More »

Summer 2017 Update to SMA Drug Pipeline is Released

We’ve recently released an update to the SMA drug pipeline. This latest version includes: 19 active programs, including one approved therapy.  14 pharmaceutical partners.  5 programs in clinical trials.  An ever-increasing breadth of potential treatment approaches to SMA. Effective Treatments for All Ages, Stages and Types of SMA Late last year, our community celebrated the

Summer 2017 Update to SMA Drug Pipeline is Released Read More »

Cure SMA Funded Standard of Care Paper Published in Neuromuscular Disorders Journal

The journal Neuromuscular Disorders has published a paper reporting on the findings of an international workgroup convened to update the Standard of Care (SOC) for SMA. Cure SMA provided funding support for this project, and Mary Schroth, medical director for Cure SMA, served on the workgroup. A SOC for SMA was first issued in 2007,

Cure SMA Funded Standard of Care Paper Published in Neuromuscular Disorders Journal Read More »

The 2017 Annual SMA Conference is Here!

The 2017 Annual SMA Conference, now in its 29th year, is set to kick off on June 29 and continue into a weekend full of programs and events that bring families, researchers and healthcare professionals together. This year’s conference has already surpassed the records of previous years. We’re expecting over 2,000 attendees, including almost 450

The 2017 Annual SMA Conference is Here! Read More »

Scroll to Top